Parenteral Prostanoids in Pediatric Pulmonary Arterial Hypertension: Start Early, Dose High, Combine-Reference-Cited by-同舟云学术

Parenteral Prostanoids in Pediatric Pulmonary Arterial Hypertension: Start Early, Dose High, Combine

Published:2022-02 Issue:2 Volume:19 Page:227-237
ISSN:2329-6933
Container-title:Annals of the American Thoracic Society
language:en
Short-container-title:Annals ATS

Author:

Douwes Johannes M.¹^ORCID,Zijlstra Willemijn M. H.¹,Rosenzweig Erika B.²,Ploegstra Mark-Jan¹,Krishnan Usha S.²,Haarman Meindina G.¹,Roofthooft Marcus T. R.¹,Postmus Douwe³,Hillege Hans L.³,Ivy D. Dunbar⁴,Berger Rolf M. F.¹^ORCID

Affiliation:

1. Center for Congenital Heart Diseases, Department of Pediatric Cardiology, Beatrix Children's Hospital, and

2. College of Physicians and Surgeons, Columbia University, New York, New York; and

3. Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands;

4. University of Colorado, Children’s Hospital Colorado, Aurora, Colorado

Funder

Sebald Foundation

Frederick and Margaret L. Weyerhaeuser Foundation

Jayden de Luca Foundation

National Institutes of Health (NIH)/National Center for Advancing Translational Sciences (NCATS) Colorado CTSA

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Reference33 articles.

1. Pediatric Pulmonary Hypertension in the Netherlands

2. Pediatric Pulmonary Hypertension

3. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

4. Outcome of Pediatric Patients With Pulmonary Arterial Hypertension in the Era of New Medical Therapies

5. Children with pulmonary arterial hypertension and prostanoid therapy: Long-term hemodynamics

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary Hypertension in Children;Clinics in Chest Medicine;2024-09

2. Embracing the challenges of neonatal and paediatric pulmonary hypertension;European Respiratory Journal;2024-08-29

3. Younger age at initiation of subcutaneous treprostinil is associated with better response in pediatric Group 1 pulmonary arterial hypertension;Pulmonary Circulation;2024-01

4. Treprostinil effectiveness in higher-risk pediatric patients with Idiopathic and Heritable Pulmonary Arterial Hypertension;Canadian Journal of Cardiology;2023-11

5. Neue Aspekte bei der pulmonalen Hypertonie im Kindesalter – kommentierte 2022ERS/ESC-PH-Guidelines;Pneumologie;2023-11